Susunod

Auto-play

MRD’s Potential Role in Treating Acute Myeloid Leukemia

0 Mga view • 07/04/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Harry Erba, MD, PhD; Alexander E. Perl, MD; Eunice Wang, MD; and Jorge E. Cortes, MD, debate the current value of minimal residual disease testing for therapeutic decision-making in acute myeloid leukemia and identify the needs to be addressed before use in standard practice.

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play